WHO ICTRP trial
Association of Graves' disease and thymic hyperplasia and the role of TSH…
NL-OMON35294 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON35294 |
|---|---|
| Public title | Association of Graves' disease and thymic hyperplasia and the role of TSH receptor antibodies in T cell development |
| Scientific title | Association of Graves' disease and thymic hyperplasia and the role of TSH receptor antibodies in T cell development - Association of Graves' disease and thymic hyperplasia |
| Primary sponsor | Erasmus MC, Universitair Medisch Centrum Rotterdam |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Observational invasive |
| Countries | Netherlands |
| Conditions | thymus hyperplasie Hyperthyroidism;10043739;Hyperthyroidism |
| Interventions | ;Graves' disease;T cell development;thymic hyperplasia;Thymus |
| Registration date | Apr 15, 2010 |
| Target size | 30 |
| Secondary IDs | NL22657.078.08 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: